Recent Updates
Recently added Catalysts
JNJ

Johnson & Johnson to Participate in the 2015 Wells Fargo 10th Annual Healthcare Conference Johnson & Johnson (NYSE: JNJ) will participate in the 2015 Wells Fargo 10th Annual Healthcare Conference on Thursday, Sept. 10, at The Hyatt Regency...

Key Takeaway: NEW BRUNSWICK, N.J. , Aug. 27, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 2015 Wells Fargo 10 th Annual Healthcare Conference on Thursday, Sept. 10 , at The Hyatt Regency Boston. Alex Gorsky, Chairman of the Board of Directors and Chief Executive

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J. , Aug. 27, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the 2015 Wells Fargo 10 th Annual Healthcare Conference on Thursday, Sept. 10 , at The Hyatt Regency Boston. Alex Gorsky, Chairman of the Board of Directors and Chief Executive Officer, will represent the Company as the keynote speaker, and is scheduled to present at 12:05 p.m. (Eastern Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast and podcast replay will be available approximately two hours after the live webcast.
Last updated: Aug 27, 2015